Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Turkish Journal of Medical Sciences

Journal

2022

Treatment

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Factors Affecting Patient-Acceptable Symptom States And Treatment Decision In Familial Mediterranean Fever, Derya Yildirim, İbrahi̇m Vasi̇, Erdi̇ Tahta, Riza Can Kardaş, Burcugül Özkiziltaş, Hami̇t Küçük, Mehmet Aki̇f Öztürk, Şemi̇nur Haznedaroğlu, Berna Göker, Abdurrahman Tufan Jan 2022

Factors Affecting Patient-Acceptable Symptom States And Treatment Decision In Familial Mediterranean Fever, Derya Yildirim, İbrahi̇m Vasi̇, Erdi̇ Tahta, Riza Can Kardaş, Burcugül Özkiziltaş, Hami̇t Küçük, Mehmet Aki̇f Öztürk, Şemi̇nur Haznedaroğlu, Berna Göker, Abdurrahman Tufan

Turkish Journal of Medical Sciences

Background/aim: Familial Mediterranean fever [FMF] is the most common autoinflammatory disease characterized by inflammatory attacks of fever and polyserositis. Patients' quality of life is significantly affected due to recurrent excruciating pain attacks and complications. This study is performed to evaluate the parameters most affecting patients' satisfaction from treatment. Materials and methods: Three hundred and forty-six consecutive patients diagnosed with FMF were enrolled in this study. Current treatment, acute phase proteins, number, type, and severity of predominant attacks, absenteeism from work/school in the last three months were recorded, and the participants were asked whether they needed additional treatment to evaluate Patient …


Remdesivir Treatment For Patients With Moderate To Severe Covid-19, İmran Hasanoğlu, Hati̇ce Rahmet Güner, İlhami̇ Çeli̇k, Fi̇kret Kanat, Ayşe Batirel, Gülçi̇n Telli̇ Di̇zman, Esma Eryilmaz Eren, Di̇lek Yildiz Sevgi̇, İlkay Bozkurt, Kadri̇ye Kart Yaşar, Sevtap Şenoğlu, Esra Kazak, Ridvan Karaali̇, Aysel Kocagül Çeli̇kbaş, Hüsnü Pullukçu Jan 2022

Remdesivir Treatment For Patients With Moderate To Severe Covid-19, İmran Hasanoğlu, Hati̇ce Rahmet Güner, İlhami̇ Çeli̇k, Fi̇kret Kanat, Ayşe Batirel, Gülçi̇n Telli̇ Di̇zman, Esma Eryilmaz Eren, Di̇lek Yildiz Sevgi̇, İlkay Bozkurt, Kadri̇ye Kart Yaşar, Sevtap Şenoğlu, Esra Kazak, Ridvan Karaali̇, Aysel Kocagül Çeli̇kbaş, Hüsnü Pullukçu

Turkish Journal of Medical Sciences

Background/aim: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treated with remdesivir, and safety and tolerability of 5 days of remdesivir treatment. Materials and methods: This multicenter prospective observational study was conducted in 14 centers in Turkey. Pregnancy or breastfeeding, multiorgan failure, or usage of vasopressors for septic shock, ALT > 5 × the upper limit of the normal range, or eGRF


Efficacy Of Transcranial Magnetic Stimulation In Treatment-Resistant Depression, Kemal Akpinar, Nalan Kalkan Oğuzhanoğlu, Tuğçe Toker Uğurlu Jan 2022

Efficacy Of Transcranial Magnetic Stimulation In Treatment-Resistant Depression, Kemal Akpinar, Nalan Kalkan Oğuzhanoğlu, Tuğçe Toker Uğurlu

Turkish Journal of Medical Sciences

Background/aim: The use of Transcranial Magnetic Stimulation (TMS) in the add-on treatment of patients with treatment-resistant depression (TRD) is becoming more common. This study aims to investigate the efficacy of TMS on depression and accompanying anxiety symptoms among patients with TRD. Materials and methods: The current study was conducted with 38 patients diagnosed with TRD. The patients were randomly divided into two groups and received 20 sessions of high-frequency (10Hz) TMS and 20 sessions of sham TMS to the left dorsolateral prefrontal cortex in a double-blind and cross-over fashion without a change in their pharmacotherapy. In the clinical evaluation, Hamilton …


Clinically Mild Encephalitis/Encephalopathy With A Reversible Splenial Lesion Of Thecorpus Callosum In Childhood: A Single-Center Experience, Hali̇l Çeli̇k, Betül Emi̇ne Deri̇nkuyu, Erhan Aksoy, Ülkühan Öztoprak, Nesri̇n Ceylan, Ebru Azapağasi, Suna Özdem, Melahat Melek Oğuz, Deni̇z Yüksel Jan 2022

Clinically Mild Encephalitis/Encephalopathy With A Reversible Splenial Lesion Of Thecorpus Callosum In Childhood: A Single-Center Experience, Hali̇l Çeli̇k, Betül Emi̇ne Deri̇nkuyu, Erhan Aksoy, Ülkühan Öztoprak, Nesri̇n Ceylan, Ebru Azapağasi, Suna Özdem, Melahat Melek Oğuz, Deni̇z Yüksel

Turkish Journal of Medical Sciences

Background/aim: Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare clinicoradiological syndrome that typically presents with central nervous system symptoms such as loss of consciousness, seizure, headache, and ophthalmoparesis. Materials and methods: Here, we highlight the characteristics of this syndrome together with the clinical and MRI findings of 6 pediatric patients with MERS. Results: Between January 2017 and October 2020, 6 patients with MERS (3 boys and 3 girls) presented to our center. The mean age was 122 ± 54.6 (min-max: 44-180) months. None of the patients had a chronic disease. In our study, infectious agents were detected …